SCA
NXTM

SAC Capital Advisors’s NxStage Medical Inc. NXTM Stock Holding History

SAC Capital Advisors’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-1,081,000
Closed -$13.8M – 1312
2014
Q1 		$13.8M Sell
1,081,000
-67,700
-6% -$883K 0.07% 342
2013
Q4 		$11.5M Buy
1,148,700
+489,618
+74% +$5.56M 0.07% 337
2013
Q3 		$8.67M Buy
659,082
+170,775
+35% +$2.24M 0.05% 418
2013
Q2 		$6.97M Buy
+488,307
New +$6.14M 0.04% 450

Other funds holding NXTM

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BA
Broadview Advisors Milwaukee, Wisconsin $324M AUM 0.76% 1-Year Est. Return

SAC Capital Advisors's NXTM Position: Q2 2014 in Review

SAC Capital Advisors sold out of NxStage Medical Inc. (NXTM) in Q2 2014, closing a stake of 1,081,000 shares — an estimated $13.8M sold.

SAC Capital Advisors first reported a position in NXTM in Q2 2013 and held it in 4 quarters. The position peaked at $13.8M in Q1 2014. 115 funds tracked by Wall St. Rank hold NXTM as of Q2 2014.

  • SAC Capital Advisors reported no remaining NxStage Medical Inc. position as of Q2 2014 after selling out during the quarter.
  • SAC Capital Advisors sold 1,081,000 NxStage Medical Inc. shares in Q2 2014, an estimated $13.8M.
  • SAC Capital Advisors first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 4 quarters.
  • SAC Capital Advisors's NxStage Medical Inc. position peaked at $13.8M in Q1 2014.
  • 115 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q2 2014.

Based on SAC Capital Advisors's 13F filing for Q2 2014.